© 2022 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.
DyeVert™ PLUS EZ Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:
Moderate and severe chronic kidney disease
DyeVert™ PLUS EZ reduces contrast dye delivery to the patient without compromising image quality.
DyeVert™ PLUS EZ clinical results show over 40% average reduction in contrast dosage injected to the patient.1
Real-time dose monitoring
DyeVert™ PLUS EZ module, smart-syringe and monitor wirelessly communicate real-time contrast monitoring throughout each procedure.
1 Desch, S. et all. Impact of a novel contrast reduction system on contrast savings in coronary angiography – The DyeVert randomized controlled trial. Int J Cardiol (2018) https://doi.org/10.1016/j.ijcard.2017.12.107
Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
Osprey Medical, Pty
Level 13, 41 Exhibition Street
Melbourne, Victoria 3000 Australia
Uncompromised Imaging: Seeing is Believing
Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS EZ reduces contrast amount without compromising image quality. See for yourself.
Without contrast reduction
With DyeVert™ PLUS EZ contrast reduction
Optimizing procedures for coronary angiography patients at-risk for kidney injury starts with DyeVert™ PLUS EZ technology.
The DyeVert™ PLUS EZ Technology
DyeVert™ PLUS EZ contrast reduction system is easy to use and incorporate into common cath-lab procedures.